Resultado final Documents, reports (2) Report on the Annual Meetings (agenda, minutes, progress report) with all participants of the consortium including the EC Scientific Officer The participants will meet annually to review the project’s progress and achievement and discuss coming activities. Five meetings will be placed: kick off, mid-terms and final meeting. Coordination and organisation of PROCROP meetings, and the preparation and distribution of the minutes of the SC will also be distributed. Report of press release and dissemination activities concerning PROCROP project The Coordinate will create a final report containing PROCROP press releases and dissemination activities in order to inform the general public. Of course, PROCROP will also include information about its activities on the webpage informing about the partners and its activities. Websites, patent fillings, videos etc. (2) PROCROP Logo, graphical Chart and webpage Design of the official PROCROP logo and graphical chart to generate visual identity for the project. Also, an official webpage will be created for PROCROP, to inform public and scientific community about different issues related to the project. Publications in reviewed journals and conference abstracts. Knowledge and publications in international high impact-factor journals (in the field of cancer and immunology). Reports of clinical trial outcomes with immunomonitoring results should result in reports submitted to the top clinical journals, either general, or specialized in oncology, given the expected efficacy and the novelty of the PROCROP approach. It is expected that the whole consortium will publish a total number of 8-15 papers, including reviews. Other (1) Knowledge/information management updated Ensuring that all participants are informed of the strategy, aims and project development. Knowledge management activities will include the set-up of the web-based management platform – (member restricted access) for sharing information among all partners. The web-based will be the repository for all PROCROP documents restricted to consortium members. Publicaciones Peer reviewed articles (14) Flexible Signaling of Myeloid C-Type Lectin Receptors in Immunity and Inflammation Autores: Carlos del Fresno, Salvador Iborra, Paula Saz-Leal, María Martínez-López, David Sancho Publicado en: Frontiers in Immunology, Issue 9, 2018, ISSN 1664-3224 Editor: Frontiers Media S.A. DOI: 10.3389/fimmu.2018.00804 Dectin-1/2–induced autocrine PGE2 signaling licenses dendritic cells to prime Th2 responses Autores: Maria M. M. Kaisar, Manuel Ritter, Carlos del Fresno, Hulda S. Jónasdóttir, Alwin J. van der Ham, Leonard R. Pelgrom, Gabriele Schramm, Laura E. Layland, David Sancho, Clarissa Prazeres da Costa, Martin Giera, Maria Yazdanbakhsh, Bart Everts Publicado en: PLOS Biology, Issue 16/4, 2018, Page(s) e2005504, ISSN 1545-7885 Editor: PLOS DOI: 10.1371/journal.pbio.2005504 Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells Autores: Michel Enamorado, Salvador Iborra, Elena Priego, Francisco J. Cueto, Juan A. Quintana, Sarai Martínez-Cano, Ernesto Mejías-Pérez, Mariano Esteban, Ignacio Melero, Andrés Hidalgo, David Sancho Publicado en: Nature Communications, Issue 8, 2017, Page(s) 16073, ISSN 2041-1723 Editor: Nature Publishing Group DOI: 10.1038/ncomms16073 Innate Immune Function of Mitochondrial Metabolism Autores: David Sancho, Michel Enamorado, Johan Garaude Publicado en: Frontiers in Immunology, Issue 8, 2017, ISSN 1664-3224 Editor: Frontiers Media S.A DOI: 10.3389/fimmu.2017.00527 Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB) Autores: Arantza Azpilikueta, Elixabet Bolaños, Valerie Lang, Sara Labiano, Maria A. Aznar, Iñaki Etxeberria, Alvaro Teijeira, Maria E. Rodriguez-Ruiz, Jose L. Perez-Gracia, Maria Jure-Kunkel, Juan M. Zapata, Manuel S. Rodriguez, Ignacio Melero Publicado en: OncoImmunology, Issue 7/1, 2017, Page(s) e1368605, ISSN 2162-402X Editor: National Center for Biotechnology Information, U.S. National Library of Medicine DOI: 10.1080/2162402X.2017.1368605 Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model Autores: Marcos Vasquez, Vladimir Paredes-Cervantes, Fernando Aranda, Nuria Ardaiz, Celia Gomar, Pedro Berraondo Publicado en: Oncotarget, Issue 8/3, 2017, ISSN 1949-2553 Editor: Impact Journals DOI: 10.18632/oncotarget.14127 Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG Autores: Christina Wefers, Gerty Schreibelt, Leon F. A. G. Massuger, I. Jolanda M. de Vries, Ruurd Torensma Publicado en: Frontiers in Immunology, Issue 9, 2018, ISSN 1664-3224 Editor: National Center for Biotechnology Information, U.S. National Library of Medicine DOI: 10.3389/fimmu.2018.01412 Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System Autores: Christina Wefers, Tjitske Duiveman-de Boer, Petra Zusterzeel, Leon Massuger, David Fuchs, Ruurd Torensma, Craig Wheelock, I. de Vries Publicado en: International Journal of Molecular Sciences, Issue 19/1, 2018, Page(s) 273, ISSN 1422-0067 Editor: Multidisciplinary Digital Publishing Institute (MDPI) DOI: 10.3390/ijms19010273 Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells Autores: A. R. Sanchez-Paulete, F. J. Cueto, M. Martinez-Lopez, S. Labiano, A. Morales-Kastresana, M. E. Rodriguez-Ruiz, M. Jure-Kunkel, A. Azpilikueta, M. A. Aznar, J. I. Quetglas, D. Sancho, I. Melero Publicado en: Cancer Discovery, Issue 6/1, 2016, Page(s) 71-79, ISSN 2159-8274 Editor: American Association for Cancer Research Inc. DOI: 10.1158/2159-8290.CD-15-0510 Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense Autores: Johan Garaude, Rebeca Acín-Pérez, Sarai Martínez-Cano, Michel Enamorado, Matteo Ugolini, Estanislao Nistal-Villán, Sandra Hervás-Stubbs, Pablo Pelegrín, Leif E Sander, José A Enríquez, David Sancho Publicado en: Nature Immunology, Issue 17/9, 2016, Page(s) 1037-1045, ISSN 1529-2908 Editor: Nature Publishing Group DOI: 10.1038/ni.3509 Making the Most of Cancer Surgery with Neoadjuvant Immunotherapy Autores: I. Melero, P. Berraondo, M. E. Rodriguez-Ruiz, J. L. Perez-Gracia Publicado en: Cancer Discovery, Issue 6/12, 2016, Page(s) 1312-1314, ISSN 2159-8274 Editor: American Association for Cancer Research Inc. DOI: 10.1158/2159-8290.CD-16-1109 Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage? Autores: Bettina Weigelin, Elixabet Bolaños, Maria E. Rodriguez-Ruiz, Ivan Martinez-Forero, Peter Friedl, Ignacio Melero Publicado en: Cancer Immunology, Immunotherapy, Issue 65/5, 2016, Page(s) 493-497, ISSN 0340-7004 Editor: Springer Verlag DOI: 10.1007/s00262-016-1818-5 Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function Autores: Marcos Vasquez, Jessica Fioravanti, Fernando Aranda, Vladimir Paredes, Celia Gomar, Nuria Ardaiz, Veronica Fernandez-Ruiz, Miriam Méndez, Estanislao Nistal-Villan, Esther Larrea, Qinshan Gao, Gloria Gonzalez-Aseguinolaza, Jesus Prieto, Pedro Berraondo Publicado en: OncoImmunology, Issue 5/8, 2016, Page(s) e1196309, ISSN 2162-402X Editor: Taylor Francis Group DOI: 10.1080/2162402X.2016.1196309 Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy Autores: Till S.M. Mathan, Johannes Textor, Annette E. Sköld, Inge Reinieren-Beeren, Tom van Oorschot, Mareke Brüning, Carl G. Figdor, Sonja I. Buschow, Ghaith Bakdash, I. Jolanda M. de Vries Publicado en: Oncotarget, 2017, ISSN 1949-2553 Editor: Impact Journals DOI: 10.18632/oncotarget.15190 Buscando datos de OpenAIRE... Se ha producido un error en la búsqueda de datos de OpenAIRE No hay resultados disponibles
